These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 24173357)
21. The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1). Foot JS; Deodhar M; Turner CI; Yin P; van Dam EM; Silva DG; Olivieri A; Holt A; McDonald IA Bioorg Med Chem Lett; 2012 Jun; 22(12):3935-40. PubMed ID: 22595173 [TBL] [Abstract][Full Text] [Related]
22. The renin-angiotensin system from conception to old age: the good, the bad and the ugly. Lumbers ER; Pringle KG; Wang Y; Gibson KJ Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):743-52. PubMed ID: 24164175 [TBL] [Abstract][Full Text] [Related]
23. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases. Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216 [TBL] [Abstract][Full Text] [Related]
24. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study. Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172 [TBL] [Abstract][Full Text] [Related]
25. Bioluminescent method for assaying multiple semicarbazide-sensitive amine oxidase (SSAO) family members in both 96- and 384-well formats. Peet GW; Lukas S; Hill-Drzewi M; Martin L; Rybina IV; Roma T; Shoultz A; Zhu X; Cazacu D; Kronkaitis A; Baptiste A; Raudenbush BC; August EM; Modis LK J Biomol Screen; 2011 Oct; 16(9):1106-11. PubMed ID: 21844327 [TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease. Hirsch S Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757 [TBL] [Abstract][Full Text] [Related]
27. The incidence and implications of aldosterone breakthrough. Bomback AS; Klemmer PJ Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561 [TBL] [Abstract][Full Text] [Related]
28. Intrarenal renin-angiotensin system in renal physiology and pathophysiology. Johnston CI; Fabris B; Jandeleit K Kidney Int Suppl; 1993 Jul; 42():S59-63. PubMed ID: 8361131 [TBL] [Abstract][Full Text] [Related]
29. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation. Yu PH; Lu LX; Fan H; Kazachkov M; Jiang ZJ; Jalkanen S; Stolen C Am J Pathol; 2006 Mar; 168(3):718-26. PubMed ID: 16507887 [TBL] [Abstract][Full Text] [Related]
30. SSAO inhibitors suppress hepatocellular tumor growth in mice. Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model. Yang W; Li H; Luo H; Luo W Life Sci; 2011 Feb; 88(7-8):302-6. PubMed ID: 21146547 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD J Med Chem; 2006 Apr; 49(7):2166-73. PubMed ID: 16570912 [TBL] [Abstract][Full Text] [Related]
33. Hypertension in children with chronic kidney disease. Shatat IF; Flynn JT Adv Chronic Kidney Dis; 2005 Oct; 12(4):378-84. PubMed ID: 16198277 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine. Kinemuchi H; Kobayashi N; Takahashi K; Takayanagi K; Arai Y; Tadano T; Kisara K; Oreland L Arch Biochem Biophys; 2001 Jan; 385(1):154-61. PubMed ID: 11361012 [TBL] [Abstract][Full Text] [Related]
35. [Management of chronic kidney disease--preventing the progression of renal disease]. Kuroki A; Akizawa T Nihon Rinsho; 2008 Sep; 66(9):1735-40. PubMed ID: 18788403 [TBL] [Abstract][Full Text] [Related]
36. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease. Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343 [TBL] [Abstract][Full Text] [Related]
37. A conformationally constrained inhibitor with an enhanced potency for β-tryptase and stability against semicarbazide-sensitive amine oxidase (SSAO). Liang G; Choi-Sledeski YM; Poli G; Chen X; Shum P; Minnich A; Wang Q; Tsay J; Sides K; Cairns J; Stoklosa G; Nieduzak T; Zhao Z; Wang J; Vaz RJ Bioorg Med Chem Lett; 2010 Nov; 20(22):6721-4. PubMed ID: 20855210 [TBL] [Abstract][Full Text] [Related]
38. Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury. Lawson J; Elliott J; Wheeler-Jones C; Syme H; Jepson R Vet J; 2015 Jan; 203(1):18-26. PubMed ID: 25475166 [TBL] [Abstract][Full Text] [Related]
39. Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions. Tylicki L; Lizakowski S; Rutkowski B J Nephrol; 2012; 25(6):900-10. PubMed ID: 22684647 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection. Lambers Heerspink HJ Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]